Hyperhidrosis Treatment in Marylebone, London

Highly effective for most patients — clinical trials show 80 to 90% reduction in sweat production at the treated area for 4 to 9 months. Onset is at 5 to 14 days. Underarm treatment is the most predictable; palm and scalp treatment shows similar efficacy with shorter duration (4 to 6 months). Patients typically describe the change as life-changing in patient-facing roles where visible sweat had affected confidence.

Yes — NICE recommends starting with a clinical-strength aluminium chloride antiperspirant (Driclor or equivalent) applied at night for 7 to 14 nights, then 1 to 2 nights a week as maintenance. For many patients with mild hyperhidrosis this is sufficient. Where the topical fails, irritates the skin, or is impractical (palm or scalp use), botulinum toxin is the recommended next step.

Underarm treatment uses a fine 30-gauge needle and 15 to 20 small injections per side; topical numbing cream is applied for 15 minutes beforehand. Most patients rate underarm discomfort as 3 to 4 out of 10. Palm injection is more uncomfortable because the palm has dense nerve supply — 5 to 6 out of 10 — and a regional nerve block can be used to reduce this where appropriate.

Underarms: 6 to 9 months typically, with a small proportion of patients getting 12 months. Palms and soles: 4 to 6 months. Scalp: 4 to 7 months. Most patients schedule maintenance treatment at the first sign of return — usually a slight increase in sweat production rather than a sudden return to baseline. With consistent treatment over years, baseline sweat production tends to drop.

In some cases. Where hyperhidrosis is documented by a GP and the patient has tried and failed topical antiperspirants and iontophoresis, some UK private medical insurers cover botulinum toxin. Approval varies widely between insurers and policies. Self-funded treatment at this clinic is £400 per area; ask your insurer first if you have a private medical policy.